Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0311 Transporter Info
Gene Name	SLC35F6
Transporter Name	ANT2-binding protein
Gene ID	54978
UniProt ID	Q8N357

Post-Translational Modification of This DT
Overview of SLC35F6 Modification Sites with Functional and Structural Information
Sequence	M A W T K Y Q L F L A G L M L V T G S I N T L S A K W A D N F M A E G C G G S K E H S F Q H P F L Q A V G M F L G E F S C L A A F Y L L R C R A A G Q S D S S V D P Q Q P F N P L L F L P P A L C D M T G T S L M Y V A L N M T S A S S F Q M L R G A V I I F T G L F S V A F L G R R L V L S Q W L G I L A T I A G L V V V G L A D L L S K H D S Q H K L S E V I T G D L L I I M A Q I I V A I Q M V L E E K F V Y K H N V H P L R A V G T E G L F G F V I L S L L L V P M Y Y I P A G S F S G N P R G T L E D A L D A F C Q V G Q Q P L I A V A L L G N I S S I A F F N F A G I S V T K E L S A T T R M V L D S L R T V V I W A L S L A L G W E A F H A L Q I L G F L I L L I G T A L Y N G L H R P L L G R L S R G R P L A E E S E Q E R L L G G T R T P I N D A S
PTM type	X-N-glycosylation X-Phosphorylation X-S-palmitoylation X-Ubiquitination X: Amino Acid

N-glycosylation
Asparagine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35F6			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	110
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC35F6 Asparagine 110 has the potential to affect its expression or activity.
Phosphorylation
Serine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35F6			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	24
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35F6 Serine 24 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35F6			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	237
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35F6 Serine 237 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC35F6			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	239
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35F6 Serine 239 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC35F6			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	354
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35F6 Serine 354 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC35F6			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	371
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35F6 Serine 371 has the potential to affect its expression or activity.
Threonine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35F6			[2]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	4
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35F6 Threonine 4 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35F6			[2]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	17
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35F6 Threonine 17 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC35F6			[2]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	22
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35F6 Threonine 22 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC35F6			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	363
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35F6 Threonine 363 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC35F6			[10] , [11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	365
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35F6 Threonine 365 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35F6			[12]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	6
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC35F6 Tyrosine 6 has the potential to affect its expression or activity.
S-palmitoylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35F6			[13]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	70
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at SLC35F6 Cystine 70 has the potential to affect its expression or activity.
Ubiquitination
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC35F6			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	199
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35F6 Lysine 199 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC35F6			[15] , [16]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	203
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC35F6 Lysine 203 has the potential to affect its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S35F6_HUMAN)
2	TiO2 with Tandem Fractionation (TAFT): An Approach for Rapid, Deep, Reproducible, and High-Throughput Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):710-721.
3	Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target. Nat Commun. 2018 Sep 11;9(1):3679.
4	Proteogenomic systems analysis identifies targeted therapy resistance mechanisms in EGFR-mutated lung cancer. Int J Cancer. 2019 Feb 1;144(3):545-557.
5	Determination of Site-Specific Phosphorylation Ratios in Proteins with Targeted Mass Spectrometry. J Proteome Res. 2018 Apr 6;17(4):1654-1663.
6	Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells. Mol Cell Proteomics. 2018 Apr;17(4):550-564.
7	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
8	Phosphoproteomic analysis reveals PAK2 as a therapeutic target for lapatinib resistance in HER2-positive breast cancer cells. Biochem Biophys Res Commun. 2018 Oct 20;505(1):187-193.
9	Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
10	Quantitative Phosphoproteome Analysis of Clostridioides difficile Toxin B Treated Human Epithelial Cells. Front Microbiol. 2018 Dec 17;9:3083.
11	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
12	Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007 Dec 14;131(6):1190-203.
13	Selective Enrichment and Direct Analysis of Protein S-Palmitoylation Sites. J Proteome Res. 2018 May 4;17(5):1907-1922.
14	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
15	Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Nat Cell Biol. 2012 Oct;14(10):1089-98.
16	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature. 2021 Jun;594(7862):246-252.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence